Literature DB >> 629634

Decreased insulin requirement in acute renal failure in diabetic nephropathy.

L A Weinrauch, R W Healy, O S Leland, H H Goldstein, J A Libertino, F J Takacs, R F Bradley, R E Gleason, J A D'Elia.   

Abstract

Twelve of 13 diabetics with azotemic nephropathy experienced exacerbation of renal failure and decreased insulin requirement after coronary angiography utilizing radiographic contrast material. The single patient who did not develop acute renal failure had no evidence of decreased insulin requirement. Eleven of 12 patients had decreased insulin requirement: mean decrement in insulin dose, 40%; mean decrement in fasting blood glucose level, 33%; mean decrement in peak blood glucose level, 42%. The 12th patient underwent peritoneal dialysis against hypertonic glucose without need of an increased insulin dose. Eight of 11 patients experienced a total of 19 insulin reactions; one patient was hypoglycemic continuously, despite infusion of glucose and discontinuation of insulin. The decrement of insulin requirement was not proportional to the rise in either serum creatinine or potassium concentrations. We suggest that when acute renal failure occurs in diabetics, decreased insulin requirement should be anticipated and the insulin dose lowered.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 629634

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

1.  Recurrent hypoglycaemia in a diabetic patient as a result of unexpected renal failure.

Authors:  Malvinder S Parmar
Journal:  BMJ       Date:  2004-04-10

Review 2.  Acute renal failure in diabetics.

Authors:  A Grenfell
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

3.  Management of hyperglycemia in patients with diabetes mellitus and chronic renal failure.

Authors:  Ch Sampanis
Journal:  Hippokratia       Date:  2008-01       Impact factor: 0.471

4.  Reversible diminished insulin requirement during acute renal failure.

Authors:  J E Naschitz; C Barak; D Yeshurun
Journal:  Postgrad Med J       Date:  1983-04       Impact factor: 2.401

5.  Oral glucose-stimulated serum C-peptide predicts successful switching from insulin therapy to liraglutide monotherapy in Japanese patients with type 2 diabetes and renal impairment.

Authors:  Hisazumi Araki; Yuki Tanaka; Syohei Yoshida; Yoshikata Morita; Shinji Kume; Keiji Isshiki; Shin-Ichi Araki; Takashi Uzu; Atsunori Kashiwagi; Hiroshi Maegawa
Journal:  J Diabetes Investig       Date:  2013-11-28       Impact factor: 4.232

6.  Should Pre-Transplant Hemoglobin A1c Be Used to Predict Post-Transplant Compliance in End-Stage Renal Disease Patients Undergoing Kidney Transplantation?

Authors:  Samantha L Terranella; Jennifer Poirier; Edie Y Chan; Martin Hertl; Oyedolamu K Olaitan
Journal:  Ann Transplant       Date:  2020-06-26       Impact factor: 1.530

7.  Anti-Hyperglycemic Agents and New-Onset Acute Myocardial Infarction in Diabetic Patients with End-Stage Renal Disease Undergoing Dialysis.

Authors:  Ting-Tse Lin; Chih-Chen Wu; Yao-Hsu Yang; Lian-Yu Lin; Jiunn-Lee Lin; Pau-Chung Chen; Juey-Jen Hwang
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.